Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Diagnostic performance of DSC perfusion MRI to distinguish tumor progression and treatment-related changes: a systematic review and meta-analysis.
Journal: Neuro-oncology advances
Published: April 07, 2022
Material Suitability Testing for Nonmedical Grade Community Face Masks to Decrease Viral Transmission During a Pandemic.
Journal: Disaster medicine and public health preparedness
Published: July 28, 2020
Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.
Journal: Radiology
Published: October 23, 2019
Distinguishing Extravascular from Intravascular Ferumoxytol Pools within the Brain: Proof of Concept in Patients with Treated Glioblastoma.
Journal: AJNR. American journal of neuroradiology
Published: August 16, 2019
Quantitative comparison of delayed ferumoxytol T1 enhancement with immediate gadoteridol enhancement in high grade gliomas.
Journal: Magnetic resonance in medicine
Published: June 28, 2017
Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care.
Journal: Journal of magnetic resonance imaging : JMRI
Published: May 04, 2017
What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent.
Journal: AJNR. American journal of neuroradiology
Published: December 22, 2016
Pseudo-extravasation rate constant of dynamic susceptibility contrast-MRI determined from pharmacokinetic first principles.
Journal: NMR in biomedicine
Published: December 12, 2016
Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab.
Journal: Fluids and barriers of the CNS
Published: November 07, 2016
Last Updated: 09/26/2026